Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Study of Empathy in MSCompleted
NCT05332951N/AUpdated Feb 2, 2024
Sponsor: Assistance Publique - Hôpitaux de Paris
Multiple Sclerosis
France
Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES)Completed
NCT04568707NAUpdated Feb 2, 2024
Sponsor: Assistance Publique - Hôpitaux de Paris
Covid19 · Neurologic Manifestations · Psychiatric Manifestations
France
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any GenesisUnknown
NCT06071949Phase 3Updated Jan 31, 2024
Sponsor: Apurano Pharmaceuticals GmbH
Pain · Pain Syndrome · Pain, Chronic · Chronic Pain
Germany
Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any GenesisUnknown
NCT06072001Phase 3Updated Jan 31, 2024
Sponsor: Apurano Pharmaceuticals GmbH
Pain · Pain Syndrome · Pain, Chronic · Chronic Pain
Germany
Unidimensional Self-Efficacy Scale for Multiple Sclerosis (USE-MS) Turkish AdaptationUnknown
NCT06231030N/AUpdated Jan 31, 2024
Sponsor: Nigde Omer Halisdemir University
Multiple Sclerosis · Self Efficacy
Turkey (Türkiye)
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple SclerosisCompleted
NCT02576717Phase 3Updated Jan 30, 2024
Sponsor: Celgene
Multiple Sclerosis
United States, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria +21 more
Gray Matter Demyelination in Primary Progressive MS at 7TUnknown
NCT04977622N/AUpdated Jan 29, 2024
Sponsor: Danish Research Centre for Magnetic Resonance
Primary Progressive Multiple Sclerosis
Denmark
Onset of Lower Urinary Tract Symptoms in Multiple Sclerosis PatientsUnknown
NCT06226831N/AUpdated Jan 26, 2024
Sponsor: University Hospital Ostrava
Lower Urinary Tract Symptoms · Multiple Sclerosis
Czechia
COVID-19 Vaccine Response in Treated MS PatientsCompleted
NCT05060354N/AUpdated Jan 25, 2024
Sponsor: Brigham and Women's Hospital
Multiple Sclerosis · Healthy
United States
Gut Microbiota Composition, Cognitive Function, and Physical Fitness in Multiple Sclerosis PatientsCompleted
NCT06220409NAUpdated Jan 24, 2024
Sponsor: Comenius University
Sclerosis, Multiple
Slovakia
Identifying and Managing Psychological Distress in Multiple Sclerosis: The COMPASS-MS StudyUnknown
NCT06222359N/AUpdated Jan 24, 2024
Sponsor: King's College London
Multiple Sclerosis · Depression · Anxiety
A Study To Determine The Effect Of Ocrelizumab On Leptomeningeal Inflammation In Multiple SclerosisWithdrawn
NCT05208840Phase 4Updated Jan 23, 2024
Sponsor: Hoffmann-La Roche
Multiple Sclerosis
Russia
Preventing the Progression of Multiple Sclerosis: Early Rehabilitative Treatment and Multimodal Assessment - Part AUnknown
NCT06219291N/AUpdated Jan 23, 2024
Sponsor: Fondazione Don Carlo Gnocchi ETS
Multiple Sclerosis
Italy
The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS PatientsRecruiting
NCT06218927N/AUpdated Jan 23, 2024
Sponsor: University Hospital Ostrava
Multiple Sclerosis · Lower Urinary Tract Symptoms
Czechia
Combined Sensitivity and Specificity of Cortical Lesions and Central Vein Sign for MS Diagnosis and Differential DiagnosisCompleted
NCT04369898N/AUpdated Jan 22, 2024
Sponsor: University Hospital, Basel, Switzerland
Multiple Sclerosis)
Switzerland
The Effects of Internet-Based and Supervised Exercise Programs in People With Multiple SclerosisUnknown
NCT06210581NAUpdated Jan 18, 2024
Sponsor: Istanbul University - Cerrahpasa
Multiple Sclerosis
Turkey (Türkiye)
EXOPULSE Mollii Suit, Spasticity, Muscular Oxygenation & Multiple Sclerosis (ENNOX 2)Unknown
NCT05912595NAUpdated Jan 18, 2024
Sponsor: Sheikh Shakhbout Medical City
Sclerosis, Multiple · MS (Multiple Sclerosis) · Spastic · Spasticity, Muscle
United Arab Emirates
Therapeutic Monitoring of Drugs Used in the Treatment of Multiple SclerosisUnknown
NCT05112484N/AUpdated Jan 18, 2024
Sponsor: University Hospital Ostrava
Multiple Sclerosis
Czechia
At-Home Gait AssessmentCompleted
NCT05724901N/AUpdated Jan 17, 2024
Sponsor: NYU Langone Health
Multiple Sclerosis
United States
Assessment of tDCS-Induced Neuronal Responses in Multiple Sclerosis (MS) With Advanced MRICompleted
NCT03564496NAUpdated Jan 17, 2024
Sponsor: NYU Langone Health
Multiple Sclerosis
United States
Evaluation of Muscle Oxidative Capacity Relationship With Muscular Endurance, Fatigue (Multiple Sclerosis).Unknown
NCT06083194N/AUpdated Jan 17, 2024
Sponsor: University Hospital, Clermont-Ferrand
Multiple Sclerosis
France
Safety of Exposure to Natalizumab During PregnancyCompleted
NCT05209815N/AUpdated Jan 16, 2024
Sponsor: University Hospital, Bordeaux
Multiple Sclerosis
France, Martinique
Intermittent Fasting in Multiple SclerosisCompleted
NCT03539094NAUpdated Jan 16, 2024
Sponsor: Washington University School of Medicine
Relapsing Remitting Multiple Sclerosis
United States
Cardiovascular Fitness of Patients With Multiple Sclerosis, Effect of Exercise on Fatigue and DepressionUnknown
NCT05671588NAUpdated Jan 16, 2024
Sponsor: University Hospital Ostrava
Multiple Sclerosis
Czechia
Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated SyndromeCompleted
NCT01817166Phase 3Updated Jan 12, 2024
Sponsor: Centre Hospitalier Universitaire de Nīmes
Multiple Sclerosis
France, Martinique

Previous page Next page